Clinical inquiries. What is the best treatment for infants with colic?

Charles A Crotteau1, Sarah Towner Wright, Anne Eglash

  • 1University of Illinois at Chicago, Chicago, IL, USA.

Insights

Infantile colic, characterized by excessive crying in healthy infants, has limited evidence-based treatments. Time is the only proven remedy, with symptoms typically resolving by six months of age.

Area of Science:

  • Pediatrics
  • Neonatology
  • Infant Health

Background:

  • Infantile colic is a common yet distressing condition in healthy infants, often leading parents to seek various treatments.
  • Despite numerous interventions, robust evidence supporting their efficacy is often lacking.

Purpose of the Study:

  • To review the evidence for various infantile colic treatments.
  • To identify effective and safe interventions for managing excessive infant crying.

Main Methods:

  • A review of small studies and randomized controlled trials (RCTs) examining different colic treatments.
  • Evaluation of evidence for hypoallergenic formulas, maternal dietary changes, reduced stimulation, dicyclomine, and herbal teas.

Main Results:

  • Some evidence suggests benefit from hypoallergenic formulas, maternal low-allergen diets, and reduced infant stimulation.
  • Dicyclomine shows effectiveness but carries significant safety concerns and is contraindicated.
  • An herbal tea demonstrated efficacy in a small RCT, but practicality is limited by required volume.

Conclusions:

  • Few treatments for infantile colic are supported by strong evidence.
  • Time is the only consistently effective intervention, with colic naturally resolving by 6 months.
  • Further research is needed to establish safe and effective treatments for infantile colic.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...